Sensorium Therapeutics Funding: $56M Raised, Series A (2025)
Sensorium Therapeutics is a Biotech company based in Boston. It has raised $56M in total funding. Latest round: Series A.
Sensorium Therapeutics funding overview
Sensorium Therapeutics is a Biotech company based in Boston. Sensorium Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2025. The round record for Sensorium Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Santé··Ventures, Route 66 Capital, CU Innovation Fund, Dolby Family Ventures, Hatteras Venture Partners, Mission Biocapital and 7 others. 13 distinct backers are named across the disclosed rounds.
Sensorium Therapeutics at a glance
Total raised
$56M
Latest round
Series A
Latest round date
August 2025
Industry
Biotech
Headquarters
Boston
Notable investors
Santé··Ventures, Route 66 Capital, CU Innovation Fund, Dolby Family Ventures, Hatteras Venture Partners, Mission Biocapital, Mockingbird Credit Partners, WPSS.bio
Frequently asked about Sensorium Therapeutics funding
How much has Sensorium Therapeutics raised?
Sensorium Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Sensorium Therapeutics?
Santé··Ventures, Route 66 Capital, CU Innovation Fund, Dolby Family Ventures, Hatteras Venture Partners, Mission Biocapital are named among the investors backing Sensorium Therapeutics.
What was the latest Sensorium Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2025.
Where is Sensorium Therapeutics based?
Sensorium Therapeutics is based in Boston.
What sector does Sensorium Therapeutics operate in?
Sensorium Therapeutics is tracked under Biotech from Boston, with $56M in disclosed funding.
When did Sensorium Therapeutics last raise?
The last disclosed Sensorium Therapeutics round closed in August 2025 at Series A.
We update the Sensorium Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
